Navigation Links
MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments
Date:5/12/2008

the quarter ended March 31, 2008 were $6.1 million, compared to total operating expenses of $4.0 million in the comparable period for 2007. The increase in operating expenses is attributable to continued business growth.

For the quarter ended march 31, 2008, net loss was $3.8 million, or $0.10 per share, compared to a net loss of $3.2 million, or $0.08 per share, for the same period in 2007. Net loss per share for the quarter ended march 31, 2008 was based on weighted average of 38,846,986 shares outstanding, compared to a weighted average of 38,900,383 shares outstanding for the comparable period in 2007.

As of March 31, 2008, cash, cash equivalents and marketable securities were $84.0 million compared to $94.6 million at December 31, 2007. The decrease in cash balance is primarily attributable to the Company's repurchase of its common stock MGT Capital investments and the purchase of shares in Medicsight PLC.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc. is a technology holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange PLC.

Medicsight PLC (AIM: MDST) is a leading developer of computer-aided detection (CAD) software solutions. Medicsight's CAD solutions help clinicians utilizing Computed Tomography (CT) scans to identify, measure and analyze suspicious pathology within the colon and lungs. The Medicsight CAD products are validated against one of the world's largest databases of verified CT scan data collected from leading healthcare institutions from around the world. Medicsight products allow radiologists and physicians to review scans more quickly and accurately -- saving both time and lives.

Medicexchange PLC provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. T
'/>"/>

SOURCE MGT Capital Investments, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
2. Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement
3. SPO Medical Retains American Capital Ventures for Investor Relations Services
4. MichBio Will Host Workshop on Capital Formation Prior to April 22 Annual Meeting
5. CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
6. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
7. RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner
8. Biotech Avoids Fall Out From Tough Quarter for Capital Markets
9. Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity investment
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Pharmasset Receives $10 Million of Working Capital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...0 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX...edical-device research and,development outsourcing...tates,announced that it had been selected to the ...e fifth consecutive year. The list recognizes the ..., media, and telecommunications,industries based o...
(Date:11/27/2009)...27 Cromoz Inc., located in Researc...n nanotube-based cancer drug delivery system in Hy..., which have functional groups on the walls that a...oped in partnership with the Indian Institute of K...s as a drug delivery vehicle with the ability to t...
(Date:11/25/2009)...Newswire/ -- Biotech firm Replikins Ltd., which ha...918 pandemic through the prediction, outbreak, and...ed its latest biochemical analysis of the virus. T..."Swine Flu") virus has dropped from its peak of 3....n the spring of 2009 to resting non-epidemic level...
(Date:11/25/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Brazil Bioethanol Market Analysis an...r.com/p0165503/Brazil-Bioethanol-Market-Analysis-a... Market Analysis and Forecasts to 2013 ,, Summ...nd forecasts of the global bioethanol market and t...
Breaking Biology Technology:WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
...June 26 Barr Pharmaceuticals,Inc. (NYSE: BRL ) t...re has,ruled in favor of its subsidiary, Barr Labo...ted by Boehringer Ingelheim Pharmaceuticals, Inc. ...R) Tablets (pramipexole,dihydrochloride) 0.125mg, ...ict Court Judge Joseph J. Farnan, Jr. found that,t...
... to Measure ROI, Balance Business Benefits with ...FALLS CHURCH, Va., and ATLANTA, June 26 Companies...constrained by the,inability to justify cost of im... Study," a new survey jointly conducted by CSC (NY...NH ), IBM and Supply Chain Management Review,magaz...
...ses New Flexibility for Pandemic Planning -, NUTL...duction of a flexible purchase program that will a...wn stockpile of Tamiflu(R) for use in a,pandemic s... adaptability,to deal with unknown factors inheren...nesses pay a nominal annual fee to "reserve",their...
Other Biology Technology:Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 2Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 3Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 4Study Reveals Greatest Barrier to Green Supply Chain Initiatives 2Study Reveals Greatest Barrier to Green Supply Chain Initiatives 3Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 2Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 3Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 4Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 5
(Date:11/25/2009)... heart pumps some 250 million liters of blood thro...fibers of the heart have to be extremely durable. ...r, vice chair of the Department of Medicine III at...r. H. A. Katus), has discovered a protein that is ...ular unit, the sarcomere. In cooperation with othe...
(Date:11/25/2009)...just as vital to your health as what you eat, foun... Studies. Their experiments in mice revealed that ...in the liverthe body,s metabolic clearinghouseis m...y,s circadian clock as conventional wisdom had it....a large number of genes completely independent of ...
(Date:11/24/2009)... today named 12 new grant recipients for 2009. The...ve work across a broad spectrum of lupus research....and potential to drive scientific discovery to ult...se of systemic lupus. , The 2009 grants go to bo...e nation and include interdisciplinary and highly ...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Jean Pol Tassin wins the 2009 ECNP Neuropsychopharmacological Award 10055 1Successful Dieters Show Unique Brain Patterns 58125 1Successful Dieters Show Unique Brain Patterns 58125 2Sambazon Introduces New Refreshing Antioxidant Elixir 58121 1Sambazon Introduces New Refreshing Antioxidant Elixir 58121 2
... Humans have regularly been introducing exotic spe... for their nutritional necessities or meet less in... or hunting. However, the particular environments ...ast introduction attempts, such as that of wild ra...hern hemisphere water courses, led to an awareness...
... CSIRO is collaborating in a NASA-funded project, ... new methods of measuring forest carbon stores on ...ground carbon store and are therefore critical in ...g the amount of carbon stored in forests over a la...ng the CSIRO-designed ECHIDNA instrument, together...
... The beaches of French Guiana constitute a major r... turtle, although a protected species, is threaten...identally caught in fishing nets, sees its egg-lay...y for their meat and their eggs. Female turtles re... lay their eggs. What happens in the interval rema...
Other Biology News:Conservation of freshwater fish biodiversity: a challenge for the countries of the South 2Conservation of freshwater fish biodiversity: a challenge for the countries of the South 3Isotope analysis reveals foraging area dichotomy for Atlantic leatherback turtles 2
Mouse Anti-Human ALPK3 Monoclonal Antibody, Unconjugated, Clone 4G4 from Abnova Corporation
...uality, Functionally-Validated, Ion Channel Cell L...ritical role in nerve and muscle function and cons...heart. Drugs that modulate ion channels have been ...thic pain, cardiac arrhythmia, hypertension, local...
Mouse Anti-Human SLC25A11 Monoclonal Antibody, Unconjugated, Clone 3G4 from Abnova Corporation
Mouse Anti-Human SYT4 Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products: